Graft-versus-host Disease Acute

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2013-06-27
Clinical Trial Update: Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease [Phase 2]
A Phase 2 trial evaluating brentuximab vedotin for steroid-resistant acute graft-versus-host disease has been withdrawn.